Cancer in Pathologically Confirmed Multiple System Atrophy

Overview

Journal Clin Auton Res

Date 2023 May 13

PMID 37178348

Authors

William P Cheshire

Shunsuke Koga

Philip W Tipton

Hiroaki Sekiya

Owen A Ross

Ryan J Uitti

Keith A Josephs

Dennis W Dickson

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to assess whether cancer occurs with increased frequency in multiple system atrophy (MSA). The pathological hallmark of MSA is glial cytoplasmic inclusions containing aggregated α-synuclein, and the related protein γ-synuclein correlates with invasive cancer. We investigated whether these two disorders are associated clinically.

Methods: Medical records of 320 patients with pathologically confirmed MSA seen between 1998 and 2022 were reviewed. After excluding those with insufficient medical histories, the remaining 269 and an equal number of controls matched for age and sex were queried for personal and family histories of cancer recorded on standardized questionnaires and in clinical histories. Additionally, age-adjusted rates of breast cancer were compared with US population incidence data.

Results: Of 269 cases in each group, 37 with MSA versus 45 of controls had a personal history of cancer. Reported cases of cancer in parents were 97 versus 104 and in siblings 31 versus 44 for MSA and controls, respectively. Of 134 female cases in each group, 14 MSA versus 10 controls had a personal history of breast cancer. The age-adjusted rate of breast cancer in MSA was 0.83%, as compared with 0.67% in controls and 2.0% in the US population. All comparisons were nonsignificant.

Conclusion: The evidence from this retrospective cohort found no significant clinical association of MSA with breast cancer or other cancers. These results do not exclude the possibility that knowledge about synuclein pathology at the molecular level in cancer may lead to future discoveries and potential therapeutic targets for MSA.

References

El Nebrisi E, Javed H, Ojha S, Oz M, Shehab S . Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors. Int J Mol Sci. 2020; 21(19). PMC: 7583812. DOI: 10.3390/ijms21197329. View

Koga S, Aoki N, Uitti R, van Gerpen J, Cheshire W, Josephs K . When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015; 85(5):404-12. PMC: 4534078. DOI: 10.1212/WNL.0000000000001807. View

Galvin J, Uryu K, Lee V, Trojanowski J . Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A. 1999; 96(23):13450-5. PMC: 23968. DOI: 10.1073/pnas.96.23.13450. View

Wullner U, Schmitz-Hubsch T, Abele M, Antony G, Bauer P, Eggert K . Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease. J Neural Transm (Vienna). 2007; 114(9):1161-5. DOI: 10.1007/s00702-007-0746-0. View

Duda J, Shah U, Arnold S, Lee V, Trojanowski J . The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol. 2000; 160(2):515-22. DOI: 10.1006/exnr.1999.7228. View

Uversky V, Li J, Souillac P, Millett I, Doniach S, Jakes R . Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem. 2002; 277(14):11970-8. DOI: 10.1074/jbc.M109541200. View

Xia C, Postuma R . Diagnosing multiple system atrophy at the prodromal stage. Clin Auton Res. 2020; 30(3):197-205. DOI: 10.1007/s10286-020-00682-5. View

Nozaki I, Kato-Motozaki Y, Ikeda T, Tagami A, Takahashi K, Ishida C . Clinical features in association with neurodegenerative diseases and malignancies. Eur Neurol. 2013; 71(3-4):99-105. DOI: 10.1159/000353995. View

He K, Wang P . Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the γ-synuclein gene. Exp Ther Med. 2015; 9(5):1727-1732. PMC: 4471698. DOI: 10.3892/etm.2015.2323. View

10.

Kollensperger M, Geser F, Ndayisaba J, Boesch S, Seppi K, Ostergaard K . Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010; 25(15):2604-12. DOI: 10.1002/mds.23192. View

11.

Xu B, Chen J, Liu Y . Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation. ACS Omega. 2022; 7(34):30281-30290. PMC: 9434619. DOI: 10.1021/acsomega.2c03534. View

12.

BRUENING W, Giasson B, Klein-Szanto A, Lee V, Trojanowski J, Godwin A . Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer. 2000; 88(9):2154-63. View

13.

Kim T, Newman A, Imberdis T, Brontesi L, Tripathi A, Ramalingam N . Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity. Hum Mol Genet. 2021; 30(23):2332-2346. PMC: 8600006. DOI: 10.1093/hmg/ddab188. View

14.

Hu H, Sun L, Guo C, Liu Q, Zhou Z, Peng L . Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res. 2009; 15(17):5485-93. DOI: 10.1158/1078-0432.CCR-08-2491. View

15.

Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H . Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol. 1996; 91(2):145-54. DOI: 10.1007/s004010050406. View

16.

Sakakibara R, Sekiguchi Y, Panicker J, Sekido N, Sugimoto H, Sugisaki Y . Female Urinary Retention Progressing to Possible Multiple System Atrophy-cerebellar Form after 12 Years. Intern Med. 2022; 61(23):3599-3604. PMC: 9790793. DOI: 10.2169/internalmedicine.8724-21. View

17.

Surgucheva I, Newell K, Burns J, Surguchov A . New α- and γ-synuclein immunopathological lesions in human brain. Acta Neuropathol Commun. 2014; 2:132. PMC: 4172890. DOI: 10.1186/s40478-014-0132-8. View

18.

Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L . Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer. 2007; 121(6):1296-305. DOI: 10.1002/ijc.22763. View

19.

Surguchov A . Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol. 2008; 270:225-317. DOI: 10.1016/S1937-6448(08)01406-8. View

20.

Zhang X, Guarin D, Mohammadzadehhonarvar N, Chen X, Gao X . Parkinson's disease and cancer: a systematic review and meta-analysis of over 17 million participants. BMJ Open. 2021; 11(7):e046329. PMC: 8256737. DOI: 10.1136/bmjopen-2020-046329. View